Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEbiquity Regulatory News (EBQ)

Share Price Information for Ebiquity (EBQ)

Share Price is delayed by 15 minutes
Get Live Data
10.60    0.00 (0.00%)
Bid:
10.20
Ask:
11.00
Spread: 0.80 (7.843%)
Market Cap: £14.73m
EBQ Live PriceLast checked at - London Stock Exchange

Intraday Ebiquity Share Chart

Directorate Change

14 Dec 2018 07:00

RNS Number : 4593K
Ebiquity PLC
14 December 2018
 

 

 Ebiquity plc

("Ebiquity" or "the Company")

 

Directorate Change

 

Ebiquity, a leading independent global media and marketing consultancy, is pleased to announce the appointment of Alan Newman as Chief Financial and Operating Officer. Alan will join the Company on 7th January 2019 and be appointed as an executive Director of the Board. Kevin McNair, currently Interim Chief Financial Officer, will step down from the role and the Board on 7th January 2019.

 

Alan has extensive public company experience having spent almost ten years as CFO of YouGov plc, the AIM-listed global market research and data analytics group. He is currently Chair of the Audit Committee of Future plc and Deputy Chair of the Quoted Companies Alliance. Prior to YouGov plc, Alan was a partner at EY and previously at KPMG where he provided board level advisory and consulting services specialising in the media, technology and telecoms sector. He is a Fellow of the Institute of Chartered Accountants in England and Wales.

 

Michael Karg, Group CEO, Ebiquity says: 

 

"Alan is an exceptional addition to Ebiquity's executive team. He brings a vital combination of public company and media sector expertise as we continue our business transformation. I and the team look forward to working closely with him."

 

Alan Newman says:

 

"Ebiquity is well positioned to take advantage of media industry trends and I feel this is an exciting time to join the business. I look forward to being part of an inspiring team and working with Michael and the Executive team to help Ebiquity to develop and successfully exploit its market opportunities."

 

 

Further information on Alan Newman

Mr Newman (full name Alan Philip Stephen Newman), aged 61 currently holds the following directorships:

Future plc

Freud Museum London (registered charity)

The Quoted Companies Alliance

Freud Museum Publications Limited

Newlawns Limited

 

 

Mr Newman has been a Director of the following companies within the last five years:

YouGov plc

YouGov Services Limited

YGV Finance Limited

YouGovStone Limited

Portent.io Limited

CoEditor Limited

Doughty Media 2 Limited

YouGov America Inc.

YouGov Deutschland GmbH

YouGov France SASU

YouGov Malaysia Sdn, Bhd

YouGov M.E. Egypt LLC

YouGov M.E. FZ-LLC

YouGov Nordic &Baltic A/S

YouGov Research Pty Limited

YouGov Thailand Company Limited

PT YouGov Consulting Indonesia

Consilium Limited, Hong Kong

 

Anyada Limited

 

There is no further information required to be disclosed pursuant to Schedule Two, paragraph (g) of the AIM rules.

14 December 2018

 

Enquiries:

 

Ebiquity plc

Michael Karg (CEO)

Mark Sanford (Company Secretary)

Via Instinctif Partners

 

Instinctif Partners

Matthew Smallwood

Guy Scarborough

 

020 7457 2020

Numis Securities Limited

Nick Westlake (NOMAD)

Michael Wharton

 

020 7260 1000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOATJBMTMBIBTAP
Date   Source Headline
30th May 20193:20 pmRNSHolding(s) in Company
1st May 20197:00 amRNSTotal Voting Rights
30th Apr 201912:30 pmRNSHolding(s) in Company
30th Apr 20197:00 amRNSAnnual Report
18th Apr 20193:05 pmRNSIssue of Shares
12th Apr 201910:45 amRNSCorrection - Issue of Shares
9th Apr 20197:00 amRNSIssue of Shares
2nd Apr 201910:55 amRNSDirector/PDMR Shareholding
1st Apr 20194:40 pmRNSIssue of Shares
27th Mar 201912:25 pmRNSDirector/PDMR Shareholding
25th Mar 20192:30 pmRNSCorrection - Dividend payment schedule
25th Mar 20197:00 amRNSUnaudited Preliminary Results
1st Mar 20192:15 pmRNSTotal Voting Rights
22nd Feb 20193:55 pmRNSIssue of Shares
18th Feb 20197:00 amRNSHolding(s) in Company
12th Feb 20197:00 amRNSPre-close Trading Update
1st Feb 20197:00 amRNSTotal Voting Rights
23rd Jan 20194:50 pmRNSReplacement: Issue of Shares
23rd Jan 20193:25 pmRNSIssue of Shares
14th Jan 20193:35 pmRNSIssue of Shares
3rd Jan 20192:55 pmRNSIssue of Shares
2nd Jan 201911:40 amRNSDirectorate Change
2nd Jan 201911:40 amRNSCompletion of the disposal of the AdIntel division
2nd Jan 20197:00 amRNSTotal Voting Rights
14th Dec 20187:00 amRNSDirectorate Change
5th Dec 20181:45 pmRNSIssue of Shares
22nd Nov 20187:00 amRNSTrading Update
22nd Nov 20187:00 amRNSStatement re CMA final clearance notification
1st Nov 20187:00 amRNSTotal Voting Rights
24th Oct 20182:40 pmRNSIssue of Shares
23rd Oct 20182:05 pmRNSHolding(s) in Company
18th Oct 20184:06 pmRNSIssue of Shares
15th Oct 20187:00 amRNSIssue of Shares
11th Oct 20187:10 amRNSStatement re CMA Provisional Findings
10th Oct 201812:15 pmRNSDirectorate Change
4th Oct 20187:00 amRNSDirector/PDMR Shareholding
2nd Oct 20187:00 amRNSDirectorate Change
1st Oct 20187:00 amRNSTotal Voting Rights
27th Sep 20189:10 amRNSIssue of Shares
25th Sep 20187:00 amRNSDirectorate Change
25th Sep 20187:00 amRNSInterim Results
3rd Aug 20188:51 amRNSDirector/PDMR Shareholding
1st Aug 20187:00 amRNSTotal Voting Rights
27th Jul 20188:59 amRNSHolding(s) in Company
27th Jul 20188:55 amRNSHolding(s) in Company
27th Jul 20187:00 amRNSIssue of Shares and Director/PDMR Shareholdings
24th Jul 20187:00 amRNSInterim Trading Update
20th Jul 20185:00 pmRNSHolding(s) in Company
11th Jul 20183:05 pmRNSAward of options
6th Jul 20183:00 pmRNSIssue of Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.